Cell and Gene Therapy Business Outlook Reports 2022: Gain Access to Twice-Monthly Publications
15 févr. 2022 05h03 HE
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering. The Twice-Monthly Publication Cell and Gene Therapy...
OcyonBio Appoints Ricardo Zayas as Chief Operating Officer
14 févr. 2022 12h00 HE
|
OcyonBio (ocyonbio.com)
AGUADILLA, Puerto Rico, Feb. 14, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC announces it has appointed Ricardo Zayas its Chief Operating Officer. OcyonBio is creating an advanced therapy contract...
Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
10 févr. 2022 16h30 HE
|
Decibel Therapeutics, Inc.
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candidate DB-OTO and Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression Across Gene Therapy Pipeline
09 févr. 2022 18h00 HE
|
Decibel Therapeutics, Inc.
- Podium presentation at Association for Research in Otolaryngology Annual MidWinter Meeting highlighting DB-OTO dose-ranging studies with expression analysis, functional recovery and tolerability...
Freeline Presents on Its Fabry and Gaucher Disease AAV-Based Gene Therapies at the 18th Annual WORLDSymposium™
08 févr. 2022 07h00 HE
|
Freeline Therapeutics
FLT190 well-tolerated with promising early efficacy in Fabry disease including sustained α-Gal A expression up to two years GALILEO-1, a first-in-human, open-label, international, multicenter Phase...
Global Viral and Non-Viral Vector Manufacturing Market 2022: Favorable Funding Scenario for Vector-Based Therapies | Rapid Uptake of Viral Vector to Develop Innovative Therapies
08 févr. 2022 04h18 HE
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and Region - Analysis and Forecast, 2021-2031"...
Adverum Biotechnologies Appoints Richard Beckman M.D. as Chief Medical Officer
07 févr. 2022 16h05 HE
|
Adverum Biotechnologies, Inc.
- Dr. Beckman, a board-certified ophthalmologist, brings 30 years of experience in ophthalmology, drug development and retinal diseases including wet age-related macular degeneration - REDWOOD CITY,...
Global Cell & Gene Therapy Markets, 2021-2022 & 2027 - New Product Approvals & Increasing Pipeline of Products & Prime Designation & Funding Support For CGT
07 févr. 2022 07h08 HE
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The cell and gene...
uniQure Announces Dosing of First Patients in European Open-Label Clinical Trial of AMT-130 Gene Therapy in Huntington’s Disease
07 févr. 2022 07h05 HE
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Feb. 07, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Global Nucleic Acid Based Gene Therapy Market Research Report 2021 Featuring Wave Life Sciences, Imugene, Caperna, Phylogica, Benitec, EGEN, BioMedica, Transgene and Copernicus Therapeutics
07 févr. 2022 04h08 HE
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...